Rapid diagnostic test

IBD EZ Vue is a non-invasive qualitative 10-minute “rapid test” which clearly differentiates active IBD from IBS. This can help doctors decide which patients require endoscopic investigation. The IBD-Scan quantitative test is highly suitable for monitoring therapeutic response and identifying recurrent disease activity, thereby assisting prescribing decisions.

The ScheBo Tumor M2-PK Stool Test brings high sensitivity to non-invasive bowel cancer screening. Unlike FOB tests, it is not dependent on bleeding from tumours or polyps and just requires a sample from only a single stool. A new independent assay service is now available. Tumor M2-PK levels in EDTA-plasma samples can help diagnose many gastrointestinal tumours and support patient monitoring.

The ScheBo Pancreatic Elastase 1 Stool Test is generally regarded as the noninvasive “test of choice” for measuring pancreatic exocrine function. The results help decide whether prescribing of costly enzyme replacement therapy is appropriate.